- BFRI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Biofrontera (BFRI) CORRESPCorrespondence with SEC
Filed: 7 Jun 22, 12:00am
Biofrontera Inc. · 120 Presidential Way, Suite 330 · Woburn, MA 01801 · USA
VIA EDGAR
June 7, 2022
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: | Biofrontera Inc. Registration Statement on Form S-1 (File No. 333-265467) Request for Acceleration of Effective Date |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Biofrontera Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (as amended, the “Registration Statement”) so that the Registration Statement will be declared effective as of 4:30 p.m. Eastern time, on June 9, 2022, or as soon thereafter as practicable. The Registrant hereby also authorizes Stephen Older and Andrew Terjesen of McGuireWoods LLP to orally modify or withdraw this request for acceleration.
Once the Registration Statement has been declared effective, please orally confirm that event with Stephen Older of McGuireWoods LLP at (212) 548-2122, or in his absence, Andrew Terjesen at (704) 343-2024.
Thank you for your assistance in this matter.
Very truly yours, | ||
Biofrontera Inc. | ||
/s/ Erica L. Monaco | ||
Name: | Erica L. Monaco | |
Title: | Chief Executive Officer |
cc: | Hermann Luebbert |
Biofrontera Inc. | |
Stephen Older | |
McGuireWoods LLP |
Biofrontera Inc. . 120 Presidential Way, Suite 330 . Woburn, MA 01801 . USA | |
Contact Phone +1 781 245 1325 . E-Mail info-us@biofrontera.com . www.biofrontera-us.com |